BD Synapsys™, versions 4.20, 4.20 SR1, and 4.30, contain an insufficient session expiration vulnerability. If exploited, threat actors may be able to access, modify or delete sensitive information, including electronic protected health information (ePHI), protected health information (PHI) and personally identifiable information (PII).
Published 2022-06-02 14:15:52
Updated 2022-06-10 02:14:47
View at NVD,   CVE.org

Exploit prediction scoring system (EPSS) score for CVE-2022-30277

0.04%
Probability of exploitation activity in the next 30 days EPSS Score History
~ 10 %
Percentile, the proportion of vulnerabilities that are scored at or less

CVSS scores for CVE-2022-30277

Base Score Base Severity CVSS Vector Exploitability Score Impact Score Score Source First Seen
3.6
LOW AV:L/AC:L/Au:N/C:P/I:P/A:N
3.9
4.9
NIST
5.7
MEDIUM CVSS:3.1/AV:P/AC:L/PR:L/UI:R/S:U/C:H/I:H/A:N
0.5
5.2
Becton, Dickinson and Company (BD)
5.7
MEDIUM CVSS:3.1/AV:P/AC:L/PR:L/UI:R/S:U/C:H/I:H/A:N
0.5
5.2
NIST

CWE ids for CVE-2022-30277

  • According to WASC, "Insufficient Session Expiration is when a web site permits an attacker to reuse old session credentials or session IDs for authorization."
    Assigned by:
    • cybersecurity@bd.com (Secondary)
    • nvd@nist.gov (Primary)

References for CVE-2022-30277

Products affected by CVE-2022-30277

This web site uses cookies for managing your session, storing preferences, website analytics and additional purposes described in our privacy policy.
By using this web site you are agreeing to CVEdetails.com terms of use!